Physician profile
Mollie K Ezzie
NPI 1427059153
$3,256.91
in general payments reported to CMS, 2019-2025
33 companies · $575 in 2025
The $575 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $69.78 · 2021: $320 · 2022: $683 · 2023: $717 · 2024: $749 · 2025: $575.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,041.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,040.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,182.07 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $311.55 | 2021-2025 | |
| Optumhealth Care Solutions, LLC | $260.07 | 2023-2025 | Eitan Medical, Vivify Health Care Team Portal 001, Zyno Solutions |
| Astellas Pharma US INC | $189.67 | 2022-2025 | Veozah, Myrbetriq |
| Biogen, INC. | $159.10 | 2024-2025 | Zurzuvae |
| Organon LLC | $145.67 | 2022-2025 | Nexplanon |
| Exeltis, USA INC. | $122.83 | 2020-2024 | Slynd |
| Agile Therapeutics, INC. | $111.25 | 2021-2023 | Twirla |
| Coopersurgical, INC. | $75.86 | 2022-2024 | Paragard T 380a, Paragard T 380a |
| Therapeuticsmd, INC. | $71.56 | 2019-2022 | |
| Aspira Women'S Health INC | $68.38 | 2021-2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $57.90 | 2020-2024 | |
| Evofem Biosciences, INC. | $45.34 | 2022 | |
| Sumitomo Pharma America, INC. | $40.32 | 2023-2025 | Myfembree |
| Allergan, INC. | $36.84 | 2019-2020 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $35.56 | 2019 | |
| Smith+Nephew, INC. | $32.83 | 2022-2023 | Pico 7 |
| Exact Sciences Corporation | $30.73 | 2023 | Cologuard Collection Kit |
| Hologic Sales and Service, LLC | $30.24 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $30.00 | 2023-2024 | |
| Baxter Healthcare | $28.68 | 2024 | Perclot |
| Millicent US INC | $19.96 | 2025 | Intrarosa |
| Daiichi Sankyo INC. | $19.61 | 2022 | |
| Urovant Sciences INC | $18.90 | 2022 | |
| Mylan Pharmaceuticals INC. | $18.80 | 2021 | |
| Pharmacosmos Therapeutics INC. | $18.76 | 2021 | |
| Gynesonics, INC. | $16.25 | 2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Shield Therapeutics INC | $13.88 | 2023 | Accrufer |
| Olympus America INC. | $13.32 | 2019 | |
| Merck Sharp & Dohme LLC | $13.26 | 2019 | |
| Avion Pharmaceuticals | $13.20 | 2023 | Balcoltra |
| Medtronic, INC. | $12.81 | 2023 | Ligasure |
| Amag Pharmaceuticals, INC. | $11.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mollie Ezzie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.